COVID-19 is an emerging, rapidly evolving situation.

Get the latest public health information from CDC: https://www.coronavirus.gov
Get the latest research information from NIH: https://www.nih.gov/coronavirus

Coronavirus Guidance for NIH Applicants and Grantees: https://grants.nih.gov/grants/natural_disasters/corona-virus.htm

PPAH reviews applications that employ epidemiologic, population-based and health services research approaches to understand HIV incidence and prevalence; structural, macro-level, or policy factors affecting HIV infection, transmission, and management; and the delivery of health services to prevent infection and ensure care for those living with HIV/AIDS.

The List of Reviewers lists all present, whether standing members or temporary, to provide the full scope of expertise present on that date. Lists are posted 30 days before the meeting and are tentative, pending any last minute changes.

Review Dates

Membership Panel

The membership panel is a list of chartered members only.

Topics


  • Studies addressing clinic-based, community, and structural factors that affect screening, testing, and access to and quality of care of those at risk for or living with HIV/AIDS.
  • Population based approaches of social, economic, or contextual studies of the impact of HIV/AIDS on communities or populations.
  • Epidemiologic studies of the incidence, prevalence, transmission, progression, prevention and treatment of HIV infection, including health disparities at the community, national and international or policy level.
  • Studies examining the impact of structural factors on HIV risk and prevention. As well as that of health services along the HIV care continuum in populations and communities.
  • Studies examining models which incorporate care for substance use and/or psychiatric disorder with HIV care in populations and communities.
  • Dissemination and implementation science studies of HIV/AIDS-related prevention, screening, and treatment interventions.
  • Studies using technology to improve the delivery of health services including tools that incorporate telehealth strategies, and that leverage electronic health record data.
  • The development and testing of behavioral biostatistical methods to examine HIV infection, transmission, risk factors, disease progression and monitoring. Such methods include social network analysis, phylodynamic tracking, mathematical modeling, big data, and simulation/computational approaches.

Shared Interests and Overlaps

HIV/AIDS Intra- and Inter-personal Determinants and Behavioral Interventions Study Section (HIBI)

  • Studies addressing the qualitative and quantitative evaluation of HIV prevention or HIV care continuum interventions at the individual level will be reviewed by HIBI, while studies of interventions at the community or population level will be reviewed by PPAH. Studies with a combination of both community and individual level interventions are assigned based on the principal outcomes of the proposed research.
  • Clinic based studies addressing HIV prevention and/or HIV care involving interventions primarily at the individual level are reviewed in HIBI, while clinic based studies involving interventions primarily at the community level are reviewed in PPAH.
  • Developmental and/or small-scale implementation science studies to establish appropriate measures and/or populations, for example, may be reviewed in HIBI.

HIV Comorbidities and Clinical Studies Study Section (HCCS): Epidemiological studies employing behavioral measures and/or behavioral outcomes are reviewed in PPAH; epidemiological studies employing biological assays and/or focusing on biological outcomes can be reviewed in HCCS.

HIV Coinfections and HIV Associated Cancers Study Section (HCAC): Studies of HIV coinfections and HIV associated cancers in human populations employing behavioral measures and/or behavioral outcomes may be reviewed in PPAH. Studies of HIV coinfections and HIV associated cancers in human populations employing biological assays and/or focusing on biological outcomes are reviewed in HCAC.

Non-AARR Overlaps:

Only applications in which there is a clear and compelling HIV/AIDS research component in the proposed research plan are eligible for the AIDS deadlines and review in PPAH and other AARR study sections. Those deemed insufficiently related to HIV/AIDS are assigned to other study sections and must be submitted in time to meet the regular non-AIDS application due dates. Applicants might consider requesting study sections in the following integrated review groups (IRGs):

Population Sciences and Epidemiology (PSE): PSE reviews epidemiologic and demographic research covering a range of diseases and health conditions in large populations.

Risk, Prevention and Health Behavior (RPHB): RPHB research interests include behavioral interventions and risk factor modification studies, and psychological and biobehavioral responses to disease screening and management.

Healthcare Delivery and Methodologies (HDM): HDM reviews clinical, community, and population research studies which examine the sociocultural, economic, environmental, and infrastructure factors that influence the delivery of health care, patient outcomes, population health, and health policies.